期刊
ONCOTARGET
卷 6, 期 25, 页码 20863-20874出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4576
关键词
small intestine cancer; p53; Kazald1; CHN2; Pathology Section
资金
- Cancer Research UK [C11512/A18067]
- Experimental Cancer Medicine Centre Network from Cancer Research UK [C36697/A15590]
- NI Health and Social Care Research and Development Division
- Sean Crummey Memorial Fund
- Tom Simms Memorial Fund
- HSC Research and Development Division of the Public Health Agency in Northern Ireland
- Cancer Research UK through the Belfast CRUK Centre
- Northern Ireland Experimental Cancer Medicine Centre
- Friends of the Cancer Centre
- Sean Crummey Foundation
- Public Health Agency [SPI/5151/15, SPI/3315/06] Funding Source: researchfish
Small bowel accounts for only 0.5% of cancer cases in the US but incidence rates have been rising at 2.4% per year over the past decade. One-third of these are adenocarcinomas but little is known about their molecular pathology and no molecular markers are available for clinical use. Using a retrospective 28 patient matched normal-tumor cohort, next-generation sequencing, gene expression arrays and CpG methylation arrays were used for molecular profiling. Next-generation sequencing identified novel mutations in IDH1, CDH1, KIT, FGFR2, FLT3, NPM1, PTEN, MET, AKT1, RET, NOTCH1 and ERBB4. Array data revealed 17% of CpGs and 5% of RNA transcripts assayed to be differentially methylated and expressed respectively (p < 0.01). Merging gene expression and DNA methylation data revealed CHN2 as consistently hypermethylated and downregulated in this disease (Spearman -0.71, p < 0.001). Mutations in TP53 which were found in more than half of the cohort (15/28) and Kazald1 hypomethylation were both were indicative of poor survival (p = 0.03, HR = 3.2 and p = 0.01, HR = 4.9 respectively). By integrating high-throughput mutational, gene expression and DNA methylation data, this study reveals for the first time the distinct molecular profile of small bowel adenocarcinoma and highlights potential clinically exploitable markers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据